Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday. The stock traded as low as $12.7480 and last traded at $12.7480, with a volume of 2082 shares traded. The stock had previously closed at $12.8650.
Analyst Upgrades and Downgrades
Separately, Zacks Research cut Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research note on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
View Our Latest Report on Sonic Healthcare
Sonic Healthcare Stock Down 0.1%
Sonic Healthcare Company Profile
Sonic Healthcare Limited is an Australia-based healthcare company that provides medical diagnostic services. Its principal business is laboratory medicine, including clinical pathology, anatomical pathology, genetics, and other testing services used by physicians, hospitals, and other healthcare providers. The company also offers medical imaging and related diagnostic services in selected markets.
Founded in 1987 and headquartered in Sydney, Sonic Healthcare has expanded from its Australian pathology operations into an international healthcare group.
Recommended Stories
- Five stocks we like better than Sonic Healthcare
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
- Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run
- Marvell Technology’s $90 Billion Revenue Goal Puts AI Execution Under a Microscope
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
